Combination according to claim 1 in which the pharmaceutically acceptable salt is selected from the group consisting of chloride, bromide, orotate, aspartate, acid aspartate, citrate, acid citrate, magnesium citrate, phosphate, acid phosphate, fumarate, acid fumarate, magnesium fumarate, glycerophosphate, lactate, maleate and acid maleate, mucate, oxalate, acid oxalate, pamoate, acid pamoate, sulphate, acid sulphate, glucose phosphate, tartrate, acid tartrate, magnesium tartrate, 2-amino ethanesulphonate, magnesium 2-amino ethanesulphonate, methanesulphonate, choline tartrate, tricloroacetate, and trifluoroacetate
It leverages the body's own structure to achieve a desired pharmacokinetic outcome
For use in cattle, sheep, swine, horses, dogs and cats
This contributes to central sensitization of pain pathways, promotes visceral afferent sensitization, and induces neurogenic inflammation
The observed changes in GAD and TH levels in retinal homogenates because of BPA exposure support this hypothesis